Denmark· DK-28106018917
Pulmozyme
A dornase alfa (desoxyribonuclease) product containing dornase alfa, registered in Denmark by Abacus Medicine A/S. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Dornase alfa (desoxyribonuclease) is registered in 11 of 19 countries.
Countries holding a registration under ATC R05CB13 (dornase alfa (desoxyribonuclease)), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Dornase alfa (desoxyribonuclease) · ATC R05CB13
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- DORNASE ALFA
- Manufacturer
- Abacus Medicine A/S
- Country
- Denmark (DK)
- ATC code
- R05CB13
- ATC class
- Dornase alfa (desoxyribonuclease)
- Defined daily dose
- 2.5 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106018917
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for dornase alfa (desoxyribonuclease).
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dornase alfa (desoxyribonuclease) · interactions on record
5 records
- 5 moderate
Most severe, free to view
- Insulin (human)A10AB01moderate
- Insulin (human)A10AC01moderate
- Insulin (human)A10AD01moderate
- Insulin (human)A10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R05CB13
Dornase alfa (desoxyribonuclease), as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3c0e8e6-31f6-4f82-ace1-3258fdebcc5f GET /v1/drugs/b3c0e8e6-31f6-4f82-ace1-3258fdebcc5f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "inhalationsvæske til nebulisator, opløsning",
"source": "dkma",
"strength": "1 mg/ml",
"auth_role": "DKMA",
"dk_drugid": "28106018917",
"substance": "DORNASE ALFA",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "43081"
}See everything about dornase alfa (desoxyribonuclease).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.